comparemela.com

Latest Breaking News On - Pat whitworth - Page 1 : comparemela.com

PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics

/PRNewswire/ Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat.

United-states
American
Andrew-wade
Pat-whitworth
Dan-forche
Chris-emery
Linkedin
Aptitude-health
Research-committee
University-of-louisville
National-cancer-institute
Prnewswire-prelude-corporation-preludedx

PreludeDx Presents Comparative Data Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT

Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores

Boston
Massachusetts
United-states
Dan-forche
Pat-whitworth
Johnb-hynes-veterans-memorial-convention-center
Prelude-corporation-preludedx
University-of-tennessee
University-of-california-san-francisco
Nashville-breast-center
National-cancer-institute
Prelude-corporation

PreludeDx™ Announces Latest Data on DCISionRT® in Multiple Presentations at the 2022 San Antonio Breast Cancer Symposium

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that.

Australia
Perth
Western-australia
United-states
San-antonio
Texas
Pat-whitworth
Dan-forche
Andrew-wade
Rachel-rabinovitch
Cory-dunn
Yvonne-zissiadis-jr

Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema

/PRNewswire/ ImpediMed Limited (ASX: IPD) is pleased to announce publication of a systematic literature review showing that early detection and intervention.

Australia
Brisbane
Queensland
Pat-whitworth
Digital-health-platform
Prnewswire-impedimed-limited
Nashville-breast-center
L-dex-found
Cost-effective
Practical-method
Monitor-breast-cancer-patients
Early-signs

Time for Universal Germline Genetic Testing in Breast Cancer

New data suggest that existing restrictive criteria for germline genetic testing for breast cancer deny patients data-informed clinical management.

New-york
United-states
Phoenix
Arizona
Tennessee
Nashville
Pat-whitworth
Julia-smith
Niloy-jewel-samadder
Nashville-breast-center
National-comprehensive-cancer-network
Langone-perlmutter-cancer-center

vimarsana © 2020. All Rights Reserved.